Skip to Main Content

Paper Details

Genomic impact of transient low-dose decitabine treatment on primary AML cells.
Blood
122
2013
5-methylcytosine, AML, Acute myeloid leukemia, DAC, DNA, canonical target genes, decitabine, imprinted genes, myeloid, patients, primary AML, primary AML cells, primary cells, stromal coculture

Datasets

Release 1.2